135 related articles for article (PubMed ID: 26429174)
21. Potentialities of differential immunohistochemical diagnosis of some follicular tumors of the thyroid gland.
Poloz TL; Shkurupiy VA
Bull Exp Biol Med; 2008 Dec; 146(6):794-6. PubMed ID: 19513386
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of CD56 and nm23 markers in papillary thyroid carcinoma.
Shahebrahimi K; Madani SH; Fazaeli AR; Khazaei S; Kanani M; Keshavarz A
Indian J Pathol Microbiol; 2013; 56(1):2-5. PubMed ID: 23924549
[TBL] [Abstract][Full Text] [Related]
23. The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma.
Yang X; Hu Y; Shi H; Zhang C; Wang Z; Liu X; Chen H; Zhang L; Cui D
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2127-2134. PubMed ID: 29951933
[TBL] [Abstract][Full Text] [Related]
24. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin.
Zarka TA; Han AC; Edelson MI; Rosenblum NG
Int J Gynecol Cancer; 2003; 13(2):240-3. PubMed ID: 12657131
[TBL] [Abstract][Full Text] [Related]
25. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
26. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid cancer stroma - histological and immunohistochemical study.
Radu TG; Ciurea ME; Mogoantă SŞ; Busuioc CJ; Grosu F; Ţenovici M; Petrescu IO; Vladu IM
Rom J Morphol Embryol; 2016; 57(2 Suppl):801-809. PubMed ID: 27833974
[TBL] [Abstract][Full Text] [Related]
28. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
30. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
31. [The study of the correlation of papillary thyroid carcinoma's invasion toward Ezrin and E-cadherin].
Liu C; Chen X; Gao Z; Liu Z; Tao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(17):789-91, 795. PubMed ID: 23214316
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical significance of Muc1, p63 protein in diffuse sclerosing variant of papillary thyroid carcinoma and conventional papillary thyroid carcinoma].
Hao Y; Jin C; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):457-61. PubMed ID: 23898609
[TBL] [Abstract][Full Text] [Related]
34. Selected immunohistochemical prognostic factors in endometrial cancer.
Markova I; Duskova M; Lubusky M; Kudela M; Zapletalová J; Procházka M; Pilka R
Int J Gynecol Cancer; 2010 May; 20(4):576-82. PubMed ID: 20686376
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
36. CD56 expression in benign and malignant thyroid lesions.
Muthusamy S; Azhar Sha S; Abdullah Suhaimi SN; Kassim N; Mahasin M; Mohd Saleh MF; Md Isa N
Malays J Pathol; 2018 Aug; 40(2):111-119. PubMed ID: 30173227
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma.
Dobashi Y; Sakamoto A; Sugimura H; Mernyei M; Mori M; Oyama T; Machinami R
Am J Surg Pathol; 1993 Apr; 17(4):375-81. PubMed ID: 7684202
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of cells with combined apoptosis and proliferation markers in thyroid tissue specimens from patients with cancer, adenoma, and autoimmune diseases.
Kazakov SP; Zabotina TN; Korotkova OV; Dzabarov AK; Kazantseva IA
Bull Exp Biol Med; 2011 Feb; 150(4):453-8. PubMed ID: 22268042
[TBL] [Abstract][Full Text] [Related]
39. Expression of Mcl-1 and Ki-67 in Papillary Thyroid Carcinomas.
Maia FF; Vassallo J; Pinto GA; Pavin EJ; Matos PS; Zantut-Wittmann DE
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):209-14. PubMed ID: 27123780
[TBL] [Abstract][Full Text] [Related]
40. Increased numbers of tumor-lysing monocytes in cancer patients.
Papewalis C; Jacobs B; Baran AM; Ehlers M; Stoecklein NH; Willenberg HS; Schinner S; Anlauf M; Raffel A; Cupisti K; Fenk R; Scherbaum WA; Schott M
Mol Cell Endocrinol; 2011 Apr; 337(1-2):52-61. PubMed ID: 21291954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]